Andy Carnero

Portfolio Manager

📍 New York, New York, United States🔄 Updated October 2026💼 9 investments📅 15 years investing🗓 Last invested Jan 2017
VC🌍 United States
9
Total investments
4
Early stage
1
Mid stage
2
Late stage
15y
Years active

Portfolio

8 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
2017
Sweet Dissent has been quietly shaking up the dessert scene for over a decade. Serving up counter culture flavors mixed with a little bit of rock n’ roll. We are best known for our cupcakes, but we also sell delicious milkshakes, mouth-watering savory snacks, a range of fresh-from-the-oven baked goods, and killer coffee. We also have ready-made layer cakes to go.
early stageRetail
Angel Investor
2015
We help IT solution providers build more successful cloud businesses. Our SaaS products and platform are designed to make it easy and efficient for IT partners to migrate, backup, and manage their customers in the cloud. 20,000 successful partners and growing. Learn more at www.skykick.com.
Angel Investor
2015
Angel Investor
2015
Human Longevity, Inc. ™ (HLI) is the genomics-based, health intelligence company creating the world’s largest and most comprehensive database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and machine learning to make novel discoveries from these data to generate personalized health insights. Our goal is to extend healthy human life by revolutionizing human health and transforming the practice of medicine. Our DNA determines so much about each of us, but other factors can also influence our health. HLI is focused on compiling and analyzing more genotypic and phenotypic data because the combination of both enables us —to generate unprecedented insights and accelerate our understanding into what makes us who we are and what we can change for a life better lived.
early stageBiotechnology
Angel Investor
2014
Oprah, Martha Stewart, The Cooking Channel, David Tutera, Today, GMA, ♥ Jarets Stuffed Cupcakes! Zagat Reviewed "Extraordinary".
late stageFood Production
Angel Investor
2014
Shyp is reimagining what it means for businesses and individuals to ship things around the world. No more standing in line, no more wrestling with cardboard — we come to your door to pick up, package, and ship your stuff at the lowest available price. With a combination of innovative technology, finely-tuned operations, and a passion for designing delightful experiences, we’re here to save you time and money on every shipment. Join the team and discover why Shyp was named one of Fast Company’s 50 Most Innovative Companies in the world.
Investor / Advisor
2012
Oprah, Martha Stewart, The Cooking Channel, David Tutera, Today, GMA, ♥ Jarets Stuffed Cupcakes! Zagat Reviewed "Extraordinary".
late stageFood Production
Angel Investor
2011
Phase Two is headquartered in the United States. The Company invests in commodity contracts, tax liens, venture capital companies, digital assets and other miscellaneous investing.
Experience · 15 entries
All (15)
Investments (9)
Founder (3)
2017
Rabid Group
Managing Partner
2017
Angel Investor
2017
Sweet Dissent has been quietly shaking up the dessert scene for over a decade. Serving up counter culture flavors mixed with a little bit of rock n’ roll. We are best known for our cupcakes, but we also sell delicious milkshakes, mouth-watering savory snacks, a range of fresh-from-the-oven baked goods, and killer coffee. We also have ready-made layer cakes to go.
early stageRetail
2015
Angel Investor
2015
We help IT solution providers build more successful cloud businesses. Our SaaS products and platform are designed to make it easy and efficient for IT partners to migrate, backup, and manage their customers in the cloud. 20,000 successful partners and growing. Learn more at www.skykick.com.
Angel Investor
2015
Angel Investor
2015
Human Longevity, Inc. ™ (HLI) is the genomics-based, health intelligence company creating the world’s largest and most comprehensive database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and machine learning to make novel discoveries from these data to generate personalized health insights. Our goal is to extend healthy human life by revolutionizing human health and transforming the practice of medicine. Our DNA determines so much about each of us, but other factors can also influence our health. HLI is focused on compiling and analyzing more genotypic and phenotypic data because the combination of both enables us —to generate unprecedented insights and accelerate our understanding into what makes us who we are and what we can change for a life better lived.
early stageBiotechnology
Show all 15 entries ↓
Investment activity
2011–2017 · 9 investments
2011120122201422015320171
Recent (last 2 years)Earlier